Vitamin B12 Dosage Guide: How Much to Take (and Why 1,000 mcg Works)
Not medical advice — this summarizes published research; a real or neurological B12 deficiency should be managed with a clinician. Methodology.
Most adults need only 2.4 mcg a day — but to correct a deficiency, even pernicious anemia, the studied dose is 1,000 mcg/day of oral B12 — trials used 1,000–2,000 mcg and a 2026 head-to-head found no advantage to the higher one. That works despite the tiny RDA because roughly 1–2% of any oral dose is absorbed by passive diffusion — no intrinsic factor required — so a 1,000 mcg tablet delivers about 10–23 mcg regardless (PMC11643782). B12 has no upper limit, so high doses are safe.
Know your dose? See the best B12 picks at that dose →
As an Amazon Associate we earn from qualifying purchases. Picks are ranked by cost per effective dose and clinical evidence, never commissions.
Quick answer: for maintenance, 2.4 mcg/day covers you — a normal diet or a multivitamin is enough. If you're correcting a deficiency or you're in a higher-risk group (vegan, over 50, on metformin or a PPI, post-bariatric), the studied dose is 1,000 mcg/day of oral B12. The table below gives the dose for each situation, and the key insight is that absorption, not intake, is what actually limits B12 — which is why high oral doses work even when injections were once thought necessary.
Why absorption — not intake — is what matters
Here's the thing that explains every B12 dose. Your gut absorbs B12 by two routes:
- The intrinsic-factor pathway — efficient, but it saturates at roughly 2.5 mcg per dose. Above that, extra B12 simply isn't absorbed this way. This pathway needs stomach acid and intrinsic factor, both of which decline with age, PPIs, and pernicious anemia.
- Passive diffusion — roughly 1–2% of any oral dose crosses the gut wall passively (rising toward ~2.3% at higher doses), no intrinsic factor required (PMC11643782).
That 1% is the whole trick. A 1,000 mcg tablet delivers roughly 10–23 mcg by passive diffusion alone — several times the daily requirement — even in someone who can't use the intrinsic-factor route at all. That's why "why would I take 1,000 mcg when the RDA is 2.4?" has a real answer: you're not taking it for the efficient pathway, you're taking it for the passive one.
That passive-diffusion math applies to any 1,000 mcg tablet, not just one brand — the cheapest verified one we track is Jarrow Formulas Methyl B-12 1000 mcg Lemon $0.11/day.
B12 dose by situation
| Situation | Dose | Notes & evidence | Verified pick |
|---|---|---|---|
| General maintenance | 2.4 mcg/day | RDA for adults (2.6 pregnancy, 2.8 lactation); diet or a multivitamin covers it (NIH ODS). | Thorne Basic Nutrients 2/Day $1.20/day — no standalone B12 is made at 2.4 mcg; a multivitamin is the format that covers it |
| Correcting a deficiency | 1,000 mcg/day oral | For ~1–3 months, then maintenance. Trials used 1,000–2,000 mcg (PMID 29543316); a 2026 head-to-head found no difference between the two (PMID 41548600). | Nature Made Vitamin B12 1000 mcg Sublingual Fast Dissolve $0.11/day |
| Vegan / vegetarian | ~25–100 mcg/day, or 1,000 mcg 2–3×/week | Practice-based prevention (no official figure); ~half of vegan men were deficient without it, in a British male cohort (PMID 20648045). | Carlyle Vitamin B12 100 mcg (200 Tablets) $0.03/day for the daily 100 mcg route; Jarrow Formulas Methyl B-12 1000 mcg Lemon $0.11/day for the 1,000 mcg 2–3×/week route |
| Over 50 / low stomach acid | 25–100 mcg/day from supplements | NIH advises adults over 50 get most of their B12 from fortified foods or supplements, because food-bound B12 absorption drops with age (NIH ODS). Deficiency prevalence rises with age (PMID 19116323). | Carlyle Vitamin B12 100 mcg (200 Tablets) $0.03/day — 100 mcg, the top of this range |
| Pernicious anemia | 1,000–2,000 mcg/day oral or IM injection | High-dose oral was non-inferior to injections in RCTs (Project OB12); injections remain standard for severe/neurological cases. | Thorne Vitamin B12 as Methylcobalamin 1 mg $0.40/day — NSF Certified, for the oral route |
| Metformin users | Check levels; 1,000 mcg/day if low | Long-term metformin lowers B12 (~19% mean drop over 4 yrs) (PMID 20488910). | Nature Made Vitamin B12 1000 mcg Sublingual Fast Dissolve $0.11/day |
| PPI / acid-suppression users | Check levels; 1,000 mcg/day if low | Long-term PPI use is associated with deficiency, though the link is debated (PMID 24327038). | Jarrow Formulas Methyl B-12 1000 mcg Lemon $0.11/day |
| Post-bariatric surgery | 1,000 mcg/day oral (or IM) | Standard supplementation after gastric bypass/sleeve (ASMBS guidelines). | Thorne Vitamin B12 as Methylcobalamin 1 mg $0.40/day |
The "1–3 months" duration in that first row isn't a round number — see how long B12 takes to work for what the correction trials actually timed, and the one exception (neurological symptoms) that changes the timeline.
Oral high-dose vs. injections: the evidence
The old assumption was that B12 deficiency — especially pernicious anemia — required injections, because those patients can't absorb B12 the normal way. But a Cochrane review of randomized trials found that 1,000–2,000 mcg/day of oral B12 raised blood levels about as well as intramuscular injections, precisely because the passive-diffusion route doesn't need intrinsic factor (PMID 29543316). The evidence base is small (a few trials, ~150 patients), so this is well-supported rather than iron-clad — injections are still the standard for severe or neurological deficiency, where guaranteed repletion matters and absorption can't be assumed (the trials compared how well each route raised levels, not how quickly). But for many people, a daily high-dose tablet does the job that used to mean a trip to the clinic.
1,000 or 2,000 mcg? A 2026 trial compared them directly
Almost every source, this page included, has quoted the correction dose as a range — 1,000–2,000 mcg/day — and left the reader to pick. In January 2026 a randomized trial in The Journal of Nutrition tested the two doses against each other for 16 weeks in adults with type 2 diabetes, peripheral neuropathy and serum B12 below 200 pg/mL (PMID 41548600).
Both doses improved neuropathy symptoms, and neither beat the other. Pain scores fell from 7.0 to 5.6 on 1,000 mcg and from 6.2 to 4.4 on 2,000 mcg, with no significant difference between the groups on any neuropathic outcome. The 2,000 mcg arm did end with higher serum B12 — which is what doubling an intake does, and is a measure of the supplement rather than of the patient.
The honest size of this: 32 people completed it, over 16 weeks, in one specific population. It is not proof that 2,000 mcg never helps anyone, and it says nothing about healthy people topping up. What it does do is put the first direct comparison behind a range that everyone has been quoting without one — and it points down, not up. Two secondary results are worth knowing and not over-reading: the 1,000 mcg group improved HbA1c, and the 2,000 mcg group showed a decline in estimated kidney filtration rate. Both are secondary outcomes in a handful of people, so they are a reason to prefer the lower dose absent a reason not to, not a safety alarm.
So: 1,000 mcg. If you are choosing a bottle to correct a confirmed deficiency, that is the dose with the evidence behind it, and the newest evidence gives you no reason to pay for more. The 5,000 mcg bottles on the shelf are selling you a bigger number, not a better outcome.
We read the shelf: it has settled on exactly the trial dose
Original research · we read 881 vitamin B12 labels filed with the NIH (of 14,384 on the market), and this section reports the 211 of them that are sold as a B12 product — 203 carried a readable dose on the Supplement Facts panel. The other 670 are multivitamins and B-complexes where B12 is one line on a long panel. Those are a different product, not a different sample of this one, and pooling them fails validation outright (median 500 mcg against 30 mcg depending which half of the read you look at). Every percentage below is against the 203 standalone labels, and each was recomputed independently in both halves of the read order before being printed.
Most supplements we have measured this way sell well past what was studied. B12 does the opposite. The median standalone B12 label is 1,000 mcg per serving — identical in both halves of our sample — which is exactly the dose the correction trials used, and about 400× the 2.4 mcg RDA. 33.5% of the shelf sits on that single number, and 63.1% is at or above it.
| Per serving | Labels | Share |
|---|---|---|
| under 100 mcg | 3 | 1.5% |
| 100-999 mcg | 72 | 35.5% |
| exactly 1,000 mcg | 68 | 33.5% |
| 1,001-4,999 mcg | 33 | 16.3% |
| 5,000 mcg or more | 27 | 13.3% |
Two things follow, and they point in opposite directions. The first is reassuring: the default bottle on the shelf is the dose with the evidence behind it, so the ordinary 1,000 mcg tablet is not a compromise. The second is the tail — 13.3% of the standalone shelf sells 5,000 mcg or more, and the 2026 head-to-head above found no added benefit even at 2,000. That eighth of the aisle is selling a number.
And if you only need maintenance, this shelf is the wrong aisle. Just 0.5% of standalone B12 labels sell 25 mcg or less — ten times the RDA is already the bottom of the range. There is effectively no such thing as a 2.4 mcg B12 tablet, which is why the table above sends the maintenance row to a multivitamin rather than to a B12 product. Standalone B12 is built for correcting a deficiency; for topping up, it is the wrong format rather than the wrong brand.
Sublingual vs. swallowed: does it matter?
Not really. A 2025 systematic review found no significant difference between sublingual, oral, and injected B12 for raising blood levels (PMC12757266). Sublingual B12 mostly ends up swallowed and absorbed through the same gut route, so the premium "under the tongue for better absorption" claim isn't supported. Pick whichever you'll take consistently.
Safety
B12 is remarkably safe — with one specific caveat. There's no established upper limit for B12, which is why 1,000 mcg (hundreds of times the RDA) is fine. The one signal worth knowing: an observational study found that long-term very-high-dose B-vitamin use (B12 above ~55 mcg/day for ~a decade) was linked to higher lung-cancer risk in men who smoke — roughly 3–4× in current male smokers — with no association in women or non-smokers (PMID 28829668). It's an association, not proof, and specific to male smokers on chronic megadoses — but if you smoke, that's worth a conversation with your doctor. Finally: neurological deficiency symptoms (numbness, balance or memory changes) need prompt treatment, because delay risks permanent damage.
Frequently asked questions
How much B12 should I take per day?
The RDA is 2.4 mcg/day for adults (2.6 pregnancy, 2.8 breastfeeding), which diet or a multivitamin covers. To correct a confirmed deficiency, the studied dose is 1,000–2,000 mcg/day of oral B12 for one to three months, then maintenance — and a 2026 trial comparing those two doses directly found no difference in symptom improvement, so 1,000 mcg is the sensible default. High doses are safe — B12 has no established upper limit.
Why do 1,000 mcg supplements work if the RDA is only 2.4 mcg?
Your gut absorbs B12 two ways. The efficient intrinsic-factor pathway saturates at ~2.5 mcg per dose, but about 1–2% of any oral dose is absorbed by passive diffusion (rising with dose), which needs no intrinsic factor. A 1,000 mcg tablet delivers ~10–23 mcg that way — which is why megadoses correct deficiency even when normal absorption is impaired.
Do I need B12 injections, or does oral work?
For most people, high-dose oral works. A Cochrane review found 1,000–2,000 mcg/day oral raised levels about as well as injections, even in pernicious anemia. The evidence base is small, so injections remain standard for severe or neurological deficiency, but oral high-dose is well-supported for many.
Is sublingual B12 better than swallowing a tablet?
Not meaningfully. A 2025 meta-analysis found no significant difference between sublingual, oral, and injected B12. Sublingual mostly ends up swallowed and absorbed the same way, so the "better absorption" claim isn't supported.
You will see 5,000 mcg lozenges everywhere, so to close the loop: they are not dangerous — B12 has no upper limit and the surplus is simply not absorbed. But the 2026 head-to-head above found no added benefit even at 2,000 mcg, so a bigger number on the bottle is not a better outcome. If you want one regardless, NOW Foods Methyl B-12 5000 mcg Lozenges $0.21/day is the one we track — at roughly double the daily cost of the 1,000 mcg pick, for no measured gain.
Related guides
- Methylcobalamin vs cyanocobalamin — which form, once you've settled the dose · Best B12 supplements
- Does B12 help energy & fatigue? · B12 for vegans
- How long does B12 take to work? — the correction timeline, by situation
- MMA test — the marker that can catch what a serum test misses
Sources
- Coelho AC, et al. The Oral Bioavailability of Vitamin B12 at Different Doses in Healthy Individuals. Nutrients. 2024. PMC11643782
- Mansour A, Amrollahi Bioky N, Gerami H, et al. Efficacy of Oral Vitamin B-12 at 1000 µg Compared with 2000 µg on Neuropathic Outcomes in Patients with Diabetic Peripheral Neuropathy and Low Serum Vitamin B-12: a Randomized Clinical Trial. J Nutr. 2026. PMID: 41548600
- Wang H, et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency (Cochrane Review). Cochrane Database Syst Rev. 2018. PMID: 29543316
- Vidal-Alaball J, et al. Oral versus intramuscular administration of vitamin B12 (Project OB12). BMC Public Health. 2012. PMC3403849
- Efficacy of sublingual and oral vitamin B12 versus intramuscular administration: a systematic review. Front Pharmacol. 2025. PMC12757266
- Gilsing AMJ, et al. Serum concentrations of vitamin B12 and folate in British omnivores, vegetarians and vegans. Eur J Clin Nutr. 2010. PMID: 20648045
- Allen LH. How common is vitamin B-12 deficiency? Am J Clin Nutr. 2009. PMID: 19116323
- de Jager J, et al. Long term treatment with metformin and risk of vitamin B12 deficiency. BMJ. 2010. PMID: 20488910
- Lam JR, et al. Proton pump inhibitor and H2-receptor antagonist use and vitamin B12 deficiency. JAMA. 2013. PMID: 24327038
- Brasky TM, et al. Long-Term, Supplemental, One-Carbon Metabolism-Related B Vitamin Use and Lung Cancer Risk. J Clin Oncol. 2017. PMID: 28829668
- NIH Office of Dietary Supplements. Vitamin B12 Fact Sheet for Health Professionals. ods.od.nih.gov